Musk, Altman and China are fighting to control a potential $320 billion market for brain implants

Elon Musk's Neuralink and Sam Altman's investment in Synchron are leading the charge in the burgeoning brain-computer interface (BCI) market, projected to reach $320 billion. The involvement of these tech titans, alongside significant Chinese investment, intensifies a global race for dominance in a field with profound implications for healthcare, human augmentation, and national security. Investors should watch for regulatory developments, technological breakthroughs, and geopolitical tensions as this high-stakes competition unfolds.